Lombard Medical, Inc. (EVARF)

Lombard Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Net Income	-31.04	-37.8	-34.75	-19.2	-13.16
Depreciation & Amortization	1.3	1.43	1.17	0.55	0.31
Other Amortization	1.04	0.48	-	0.03	-
Loss (Gain) From Sale of Assets	0.39	0.07	-	-	-
Asset Writedown & Restructuring Costs	3.36	-	-	-	-
Stock-Based Compensation	1.11	2.78	2.54	1.18	-0.41
Other Operating Activities	1.94	0.98	-0.22	-0.89	1.3
Change in Accounts Receivable	0	-0.19	-0.48	-1.92	0.52
Change in Inventory	-1.48	-1.78	-1.84	-0.12	0.56
Change in Accounts Payable	-1.82	0.23	-0.79	2.6	-1.03
Operating Cash Flow	-25.2	-33.8	-34.37	-17.79	-11.91
Capital Expenditures	-0.27	-1.24	-1.48	-1.81	-0.22
Sale of Property, Plant & Equipment	0.12	-	-	-	-
Cash Acquisitions	-	-0.2	-	-	-
Sale (Purchase) of Intangibles	-	-0.02	-0.27	-2.07	-
Other Investing Activities	0.05	0.09	0.17	-	-
Investing Cash Flow	-0.09	-1.37	-1.58	-3.88	-0.22
Long-Term Debt Issued	12.41	21	-	2.5	4.78
Total Debt Issued	12.41	21	-	2.5	4.78
Long-Term Debt Repaid	-	-5.33	-	-	-
Total Debt Repaid	-	-5.33	-	-	-
Net Debt Issued (Repaid)	12.41	15.67	-	2.5	4.78
Issuance of Common Stock	5	-	55	55.34	-
Other Financing Activities	-1.6	-1.13	-5.34	-2.18	-0.25
Financing Cash Flow	15.81	14.54	49.66	55.66	4.53
Foreign Exchange Rate Adjustments	-2.05	-0.38	-1.24	2.42	0.43
Net Cash Flow	-11.54	-21	12.47	36.42	-7.17
Free Cash Flow	-25.46	-35.04	-35.85	-19.6	-12.13
Free Cash Flow Margin	-209.22%	-231.81%	-270.05%	-281.59%	-196.42%
Free Cash Flow Per Share	-1.26	-1.97	-2.46	-2.18	-2.41
Cash Interest Paid	1.45	0.69	-	0.16	0.29
Cash Income Tax Paid	0.01	-2.58	-1.17	0.03	-1.48
Levered Free Cash Flow	-17.21	-20.31	-22.8	-15.12	-8.05
Unlevered Free Cash Flow	-15.94	-19.69	-22.75	-14.84	-7.63
Change in Working Capital	-3.3	-1.73	-3.11	0.56	0.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.